Incidence and prevalence of atrial fibrillation among individuals with chronic kidney disease
Wing SL, Jeyakumar N, Kang Y, Stirling K, Wald R, Harel Z. Kidney Med. 2025; 8(2): 101184.
Publications
Glucagon-like peptide 1 receptor agonists and the risk of emergency department visits and hospitalization in patients with chronic kidney disease
Yau K, Ray JG, Jeyakumar N, Luo B, Abdullah S, McArthur E, Dixon SN, Wing S, Clemens KK, Castrillon-Ramirez F, Udell JA, Meraz-Munoz A, Young A, Harel Z, Perl J, Sridhar VS, Ni H, Yi TW, Leiter LA, Garg AX, Cherney DZI, Wald R. Diabetes Care. 2025; dc242811. Epub 2025 Jun 26.
Association of primary care continuity with home dialysis, transplantation, and utilization of medical services for patients starting hemodialysis
Wyman CS, Djerboua M, Clemens KK, Harel Z, Sood MM, Silver SA. Kidney Med. 2025; 7(6):101015. Epub 2025 Apr 29.
SGLT2 inhibitors and risk for hyperkalemia among individuals receiving RAAS inhibitors
Wing S, Ray JG, Yau K, Jeyakumar N, Abdullah S, Luo B, Cherney DZI, Harel Z, Hundemer GL, Mavrakanas TA, Molnar AO, Odutayo A, Perl J, Young A, Charytan D, Weir M, Wald R. JAMA Intern Med. 2025; Apr 28 [Epub ahead of print].
Safety and effectiveness of apixaban versus warfarin by kidney function in atrial fibrillation: a binational population-based study
Lam D, Scaria A, Andrade J, Badve SV, Birks P, Bota SE, Campain A, Djurdjev O, Garg AX, Harel Z, Hemmelgarn B, Hockham C, James MT, Jardine MJ, Levin A, McArthur E, Ravani P, Shao S, Sood MM, Tan Z, Tangri N, Whitlock R, Gallagher M, Jun M, Ha JT. Kidney360. 2025; Apr 9 [Epub ahead of print].
Clinical outcomes and healthcare utilization in patients receiving maintenance dialysis after the onset of the COVID-19 pandemic in Ontario, Canada
Naylor KL, Jeyakumar N, Kang Y, Dixon SN, Garg AX, Al-Jaishi A, Blake PG, Chanchlani R, Fu L, Harel Z, Ip J, Kitchlu A, Kwong JC, Nesrallah G, Oliver MJ, Stukel TA, Wald R, Weir M, Yau K. Can J Kidney Health Dis. 2025; 12:20543581251328077.
Rhabdomyolysis and sodium-glucose-linked transport inhibitors in patients taking statins
Harel Z, Jeyakumar N, Smith G, Ray JG, Clemens KK, Juurlink DN. JAMA Netw Open. 2024; 7(11):e2446641.
Periconceptional serum creatinine and risk of childhood autism spectrum disorder: a research letter
Harel Z, Jeyakumar N, Kang Y, Velez MP, Dayan N, Ray JG. Can J Kidney Health Dis. 2023; Dec 29 [Epub ahead of print].
Preconception SGLT2 or DPP4 inhibitor use and adverse pregnancy outcomes
Ray JG, Harel Z, Gilbert RE, Wald R, Berger H, Park AL. Diabetes Res Clin Pract. 2023; 205:110946. Epub 2023 Oct 7.
Safety and effectiveness of rivaroxaban versus warfarin across GFR levels in atrial fibrillation: a population-based study in Australia and Canada
Ha JT, Scaria A, Andrade J, Badve SV, Birks P, Bota SE, Campain A, Djurdjev O, Garg AX, Harel Z, Hemmelgarn B, Hockham C, James MT, Jardine MJ, Lam D, Levin A, McArthur E, Ravani P, Shao S, Sood MM, Tan Z, Tangri N, Whitlock R, Gallagher M, Jun M. Kidney Med. 2023; 5(7):100675. Epub 2023 May 16.